Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Accenture
Johnson and Johnson
Express Scripts
Fish and Richardson
Merck
Cantor Fitzgerald
Cipla
Cerilliant

Generated: February 16, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE

« Back to Dashboard

Clinical Trials for Lidocaine Hydrochloride Preservative Free

Trial ID Title Status Sponsor Phase Summary
NCT00468429 Subconjunctival Bevacizumab to Prevent Bleb Failure After Glaucoma Filtration Surgery Unknown status Grewal Eye Institute Phase 4 This study analyzes the safety and efficacy of off-label Subconjunctival Injection of bevacizumab (Avastin) versus 0.02% mitomycin C (MMC) for preventing bleb failure following glaucoma filtration surgery.
NCT00948103 The Interest of the Nitrous Oxide During Intravesical Injection of Botulinum Toxin A Completed Assistance Publique - Hôpitaux de Paris Phase 3 Second line treatment for detrusor hyperreflexia is the intravesical BTX-A injections. First 300 units Botox are diluted with 30 ml of preservative-free saline. Using a rigid cystoscope and an injection needle, BTX-A is injected into 30 sites within the detrusor muscle. The used of KALINOX® (50% nitrous oxide and oxygen) inhalation has demonstrated analgesic efficacy in various procedures (obstetric, liver biopsy, transrectal ultrasound guided prostate biopsy, emergency) The aim of this study is to investigate the safety and efficacy of analgesia with N2O/O2 inhalation for detrusor BTX-A injections using a rigid cystoscope.
NCT01905137 Botulinum Toxin Type A Versus Saline Trigger Point Injections for Myofascial Pelvic Pain Recruiting Allergan N/A The purpose of this study is to determine whether there is a change in patient-reported pelvic pain following pelvic floor injections of 200 units of Botox compared with 20cc of normal saline.
NCT01905137 Botulinum Toxin Type A Versus Saline Trigger Point Injections for Myofascial Pelvic Pain Recruiting Boston Urogynecology Associates N/A The purpose of this study is to determine whether there is a change in patient-reported pelvic pain following pelvic floor injections of 200 units of Botox compared with 20cc of normal saline.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Lidocaine Hydrochloride Preservative Free

Condition Name

Condition Name for Lidocaine Hydrochloride Preservative Free
Intervention Trials
Injection Site Vesicles 1
Pain 1
Video Assisted Thoracic Surgery 1
Hypotension Drug-Induced 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Lidocaine Hydrochloride Preservative Free
Intervention Trials
Hypotension 1
Cataract 1
Peripheral Nervous System Diseases 1
Capsule Opacification 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Lidocaine Hydrochloride Preservative Free

Trials by Country

Trials by Country for Lidocaine Hydrochloride Preservative Free
Location Trials
United States 6
France 1
Egypt 1
India 1
Saudi Arabia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Lidocaine Hydrochloride Preservative Free
Location Trials
California 3
Illinois 1
Pennsylvania 1
Massachusetts 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Lidocaine Hydrochloride Preservative Free

Clinical Trial Phase

Clinical Trial Phase for Lidocaine Hydrochloride Preservative Free
Clinical Trial Phase Trials
Phase 4 4
Phase 3 2
Phase 2 1
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Lidocaine Hydrochloride Preservative Free
Clinical Trial Phase Trials
Not yet recruiting 7
Recruiting 3
Unknown status 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Lidocaine Hydrochloride Preservative Free

Sponsor Name

Sponsor Name for Lidocaine Hydrochloride Preservative Free
Sponsor Trials
Fayoum University Hospital 1
Cairo University 1
Medical College of Wisconsin 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Lidocaine Hydrochloride Preservative Free
Sponsor Trials
Other 14
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Fuji
Medtronic
Baxter
McKesson
Boehringer Ingelheim
Citi
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.